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Sox2 is a key player in the maintenance of pluripo-
tency and stemness, and thus inhibition of its func-
tion would abrogate the stemness of pluripotent cells
and induce differentiation into several types of cells.
Herein we describe a strategy that relies on a combi-
nation of Sox2 inhibition with lineage-specific induc-
tion to promote efficient and selective differentiation
of pluripotent P19 cells into neurons. When P19 cells
transducedwith Skp protein, an inhibitor of Sox2, are
incubated with a neurogenesis inducer, the cells are
selectively converted into neurons that generate de-
polarization-induced sodium currents and action po-
tentials. This finding indicates that the differentiated
neurons are electrophysiologically active. Signaling
pathway studies lead us to conclude that a combina-
tion of Skp with the neurogenesis inducer enhances
neurogenesis in P19 cells by activating Wnt and
Notch pathways. The present differentiation protocol
could be valuable to selectively generate functionally
active neurons from pluripotent cells.
INTRODUCTION
Pluripotent stem cells (PSCs) possess two important properties,
including indefinite self-renewal and the ability to differentiate
into most cell types (Masui et al., 2007; Thomson et al., 1998).
These unique features of PSCs make them invaluable tools not
only for exploitation as therapeutic agents in regenerative medi-
cine but also for elucidation of the molecular mechanisms regu-
lating proliferation and differentiation of stem cells. PSCs are
also able to self-renew throughout life in a location-specific
manner, and their fate can be modulated through pharmacolog-
ical interventionwith small molecules (Wurdak et al., 2010). Differ-
entiation of PSCs is a multistep process that includes generation
of lineage-committed progenitors and terminal differentiation into
specific cell types. Although a number of efforts have been made
to differentiate PSCs into specific cell types (Burridge et al., 2014;
Dinget al., 2003), inparticular usingsmallmolecules (termedsmall
molecule-based cellular alchemy) (Kim et al., 2014), additional
studies are needed to uncover novel substances and conditions1512 Chemistry & Biology 22, 1512–1520, November 19, 2015 ª2015that can be employed to fine tune the differentiation process to
achieve the specific commitment with high efficiency.
Accumulating evidence suggests that maintenance of pluripo-
tency and differentiation into lineage-committed progenitors of
PSCs are tightly regulated by the interplay of a few transcription
factors termed master stemness regulators, such as octamer-
binding transcription factor 4 (Oct4), sex determining region
Y-box 2 (Sox2), and Nanog (Boyer et al., 2005; Chambers and
Tomlinson, 2009). Sox2, along with others, acts not only as a
gatekeeper of stemness but also plays a critical role in suppress-
ing neuronal and cardiac differentiation of PSCs (Graham et al.,
2003; Nishiyama et al., 2009; Stefanovic et al., 2009). Conse-
quently, once Sox2 function is abrogated, PSCs start differenti-
ating into lineages including neurons and cardiomyocytes. Owing
to its biological significance, Sox2 has become an important
target of studies of induced pluripotency or directing differentia-
tion. For example, inhibition of the transcription activity of Sox2
by Skp, a 17-kDa Escherichia coli molecular chaperone protein,
resulted in early appearance of neuronal and cardiac progenitors
from pluripotent cells (De et al., 2014). Since Skp-induced pro-
genitor formation was nonselective toward any particular lineage,
we hypothesized that treatment of lineage-specific inducers sup-
plemented by Skp-mediated stemness inhibition might lead to
optimal lineage commitment into specific cell types.
To test this hypothesis, we attempted to convert pluripotent
P19 cells into functionally active neurons by treatment with
Skp followed by synthetic small molecule neurogenesis in-
ducers. The results show that this newprotocol leads to selective
generation of electrophysiologically active neurons with effi-
ciencies that are significantly higher than those achieved by
treatment with Skp alone. Therefore, the results of this study
demonstrate that an intelligent combination of stemness sup-
pression and exclusive lineage-specific activation can be used
to obtain lineages with high efficiencies of commitment. Conse-
quently, the new approach represents an important advance in
developing strategies to achieve efficient stem cell differentiation
with well-defined conditions.
RESULTS
P19 Cells Are Efficiently Differentiated into Neurogenic
Cells by Sequential Treatment with Skp and a Small
Molecule Neurogenesis Inducer
Because treatment of pluripotent cells with Skp, engineered to
contain a cell-penetrating TAT peptide and a nuclear localizationElsevier Ltd All rights reserved
Figure 1. Neurogenesis of P19 Cells Induced
by Sequential Treatment with Skp and Neu-
rogenesis Inducers
(A) Structure of Nz and Nzl.
(B–D) P19 cells transduced with Skp (20 mg/ml)
were allowed to be aggregated for 3 days. The re-
sulting embryoid bodies were cultured in a mono-
layer for 10 days in the absence or presence of 3 mm
Nz, 4 mm Nzl, or 0.1 mm RA. The cells were immu-
nostained with neuron-specific antibodies (scale
bar represents 50 mm). The transcriptional levels of
neuron-specific markers in treated P19 cells were
examined by using (C) western blot and (D) RT-PCR
analyses. Treatment conditions are indicated in the
top of each lane. ‘‘Untreated’’ indicates that P19
cells are not treated with Skp or any neurogenesis
inducer.signal (NLS) at the N terminus (TAT-NLS-Skp), led to early differ-
entiation into neuronal and cardiac progenitors (De et al., 2014),
we initially examined how the cell fate is affected by Skp trans-
duction. Toward this end, key genes related to stemness and
early lineage-specific differentiation in Skp-transduced P19 cells
were analyzed using RT-PCR. The results show that stemness-
related genes (Fgf4, Fgf5, Utf1, Oct4, and Nanog) (Masui et al.,
2007) are down-regulated in Skp-transduced cells, and concom-
itantly genes associated with lineage-specific differentiation
(Bmp5, Need4, Gadd45b, Sox1, Sox13, Nnmt, Sox6, Sox7,
Sox9, andGATA4) (Avilion et al., 2003; Seo et al., 2011) were up-
regulated (Figure S1). This finding suggests that inhibition of
Sox2 activity by Skp abrogates the stemness of P19 cells and
subsequently initiates differentiation.
As manifested by the appearance of several lineage-specific
and germ-layer markers, suppression of stemness enhances
the process of differentiation of pluripotent cells into multiple lin-
eages (De et al., 2014). We therefore reasoned that Skp-trans-
duced P19 cells could be directed toward a specific lineage
with high efficiency by supplementing the process with line-
age-specific inducers. To probe this proposal, we carried out a
study to uncover a suitable approach that could efficiently and
selectively induce neuronal differentiation in Skp-transduced
P19 cells. For this, P19 cells transduced with Skp were grown
in suspension for 3 days, and the resulting embryoid bodies
(EB) were cultured in a monolayer for an additional 10 days in
the presence of a synthetic neurogenic inducer, neurodazine
(Nz) or neurodazole (Nzl) (Figure 1A) (Halder et al., 2015; Kim
et al., 2014; Williams et al., 2007, 2008). In addition, Skp-trans-
duced P19 cells were also exposed to retinoic acid (RA), which
is a well-known neurogenic agent (Jones-Villeneuve et al.,
1982), under the same culture conditions. Immunocytochemical
analysis of the treated cells was performed using several anti-Chemistry & Biology 22, 1512–1520, November 19, 2015bodies against neuron-specific markers
including Tuj1 (neuron-specific class III
b-tubulin), microtubule-associated protein
2 (MAP2), neurofilament 200 (NF200), and
neuron-specific enolase (NSE). The results
reveal that P19 cells treated with Skp
alone are differentiated into neurogenic
cells with a low efficiency (<10%) as
demonstrated through immunostaining with a pan-neuronal
marker Tuj1 (Figures 1B and S2A). In contrast, sequential treat-
ment of cells with Skp and either Nz or Nzl induces neurogenesis
of P19 cells with a much higher efficiency (50%–55%) (Figures
1B, S2A, and S3), a phenomenon that is also observed in cells
sequentially treated with Skp and RA. In order to probe the sig-
nificance of sequential treatment on neurogenesis, P19 cells
were allowed to form EB for 3 days in the absence of Skp, and
were subsequently cultured as a monolayer with Nz, Nzl, or RA
for a span of 10 days. Immunocytochemical analysis indicates
that P19 cells devoid of Skp transduction during EB formation
are rarely differentiated into neurogenic cells, even when neuro-
genic inducers are present at the later stage (Figure S2B). It
should be noted that specific chemical inducers, such as
DMSO and RA, are normally added to P19 cell cultures during
EB formation for efficient differentiation into cardiogenesis and
neurogenesis, respectively (van der Heyden and Defize, 2003).
Thus, P19 cells untreated with Skp during EB formation were
only inefficiently converted to neurogenic cells, even though
chemical inducers were added to the cell culture at the differen-
tiation phase. These results indicate that efficient neuronal differ-
entiation in P19 cells results from treatment with both Skp and a
small molecule neurogenesis inducer.
The enhanced neurogenesis efficiency was further examined
by using western blot analysis of neuron-specific markers.
Consistent with the results obtained using immunocytochemical
analysis, Skp-treatment followed by Nz, Nzl, or RA markedly
enhanced the expression of neuronal markers in P19 cells in
comparison to treatment with Skp alone (Figure 1C). The results
of RT-PCR analysis also reveal that induction of neuronal differ-
entiation of P19 cells is preferentially promoted by sequential
treatment rather than by treatment with Skp alone (Figure 1D).
Specifically, neuronal basic-helix-loop-helix (bHLH) factors,ª2015 Elsevier Ltd All rights reserved 1513
Figure 2. Skp-Transduced P19Cells Are Not
Differentiated into Cardiac Cells by Treat-
ment with Neurogenesis Inducers
(A) P19 cells transduced with Skp (20 mg/ml) during
EB formation were incubated for 10 days without
and with 3 mmNz, 4 mmNzl, or 0.1 mmRA. The cells
were stained with antibodies against neuronal
(Tuj1, green; MAP2, red) and cardiac markers
(Nkx2.5, red; MHC-II, green) (scale bar represents
50 mm). The nucleus of the cells was stained with
DAPI (blue). The expression levels of cardiac
markers in untreated or treated P19 cells were
examined by using (B) western blot and (C) RT-
PCR analyses. Treatment conditions are indicated
in the top of each lane. ‘‘Untreated’’ indicates that
P19 cells are not treated with Skp or any neuro-
genesis inducer.such as NeuroD andMash1 (Lo et al., 1991), as well as neuronal
marker genes, were found to be highly expressed in sequentially
treated P19 cells compared with cells treated with Skp alone.
However, mRNA levels of pluripotent markers, such as Oct4
and Nanog (Ramalho-Santos et al., 2002), were abolished in
P19 cells that were sequentially treated, as well as those that
were treated with Skp alone (Figure 1D). To further support the
above findings, comparative transcriptome analyses were con-
ducted using mouse DNA chips. The results of gene expression
profiling show that genes related to neurogenesis, synaptic
transmission/axonogenesis, and ion channels are more upregu-
lated in P19 cells sequentially treated with Skp and Nz than in
cells treated with Skp only (Table S1). Taken together, the results
support the conclusion that sequential treatment with Skp and a
neurogenic inducer enhances neurogenesis in pluripotent cells
more efficiently than treatment with Skp alone. In addition, the
findings also suggest that Skp-mediated suppression of stem-
ness could be used as a generic initial step in achieving highly
efficient commitments.
Skp-Transduced P19 Cells Are Not Converted to
Cardiomyocytes and Astrocytes after Treatment with
Either Nz or Nzl
The results of previous studies have shown that Skp transduc-
tion induces early differentiation of P19 cells into neuronal and
cardiac progenitors (De et al., 2014). Based on the early obser-
vations, we analyzed the effect of sequential treatment with
Skp and Nz, Nzl, or RA on lineage-specific differentiation of
P19 cells. As shown in Figure 2A, treatment with Skp alone eli-
cited both neurogenesis and cardiogenesis of P19 cells, as in-
ferred from positive immunostaining with antibodies against
cardiomyocytes (MHC-II and Nkx2.5) and neuron-specific
markers (Tuj1 and MAP2). In marked contrast, sequential treat-
ment with Skp and Nz, Nzl, or RA almost completely sup-
pressed Skp-induced cardiac differentiation of P19 cells, while
it exclusively directed cells toward neuronal differentiation (Fig-
ure 2A). These results were supported by the results of western
blot analysis. Whereas Skp-transduced P19 cells expressed1514 Chemistry & Biology 22, 1512–1520, November 19, 2015 ª2015 Elsevier Ltd All rights rcardiac markers, Skp-treated P19 cells
in the presence of inducers did not (Fig-
ure 2B). These findings gained furthersupport by the results of RT-PCR analysis, which also showed
that high mRNA levels of cardiac lineage markers (MHC-II,
Nkx2.5, Desmin, and GATA4) were only produced in Skp-trans-
duced P19 cells (Figure 2C). DNA chip analysis also indicates
that cardiogenesis-related genes are not significantly ex-
pressed in P19 cells when they are sequentially treated with
Skp and Nz (Table S2). The combined results show that Nz
or Nzl promotes neuronal differentiation, especially in a way
that overrides the cardiac progenitor-promoting capacity of
Skp in P19 cells.
It is known that P19 cells have the capacity to be differentiated
into astrocytes upon treatment with RA (Jones-Villeneuve et al.,
1982). This finding led us to the question whether sequential
treatment with Skp and Nz, Nzl, or RA induced differentiation
of P19 cells into astrocytes. To gain information about this issue,
expression levels of astrocyte markers, such as glial fibrillary
acidic protein (GFAP) and S100, were examined. Immunostain-
ing analysis shows that P19 cells sequentially treated with Skp
and RA express high levels of GFAP and S100, but astrocyte-
positive cells are rarely observed when P19 cells are treated
with Skp and Nz or Nzl (Figures 3A and 3B). The astrocyte-pre-
cluding activities of Nz or Nzl in Skp-transduced P19 cells
were further demonstrated by employing RT-PCR analysis of
astrocyte markers. Consistently, the results show that treatment
of P19 cells with Skp and RA leads to increased mRNA levels of
GFAP and S100 marker genes, but that treatment of P19 cells
with Skp and either Nz or Nzl does not elicit expression of these
two genes (Figure 3C). Analysis of DNA chip data also consis-
tently shows that the expression levels of gliogenesis-related
genes are not changed significantly in P19 cells sequentially
treated with Skp and Nz (Table S3). Collectively, phenotypic
studies have served to demonstrate that Nz or Nzl treatment en-
hances neurogenesis but not cardiogenesis or astrogenesis in
Skp-transduced P19 cells, whereas RA treatment promotes
neurogenesis as well as astrogenesis in Skp-transduced P19
cells. These findings indicate that Nz and Nzl are more selective
and efficient neurogenesis inducers in Skp-transduced P19 cells
than RA.eserved
Figure 3. Skp-Transduced P19 Cells Are Not
Differentiated into Astrocytes by Treatment
with Neurogenesis Inducers
(A) P19 cells transduced with Skp (20 mg/ml) during
EB formation were incubated for 10 days with 3 mm
Nz, 4 mm Nzl, or 0.1 mm RA, and without any chem-
ical. The cells were stained with antibodies against
neuron (Tuj1, green) and astrocyte-specific markers
(GFAP and S100, red) (scale bar represents 50 mm).
Thenucleusof thecellswasstainedwithDAPI (blue).
The expression levels of astrocyte markers in un-
treated or treated P19 cells were examined using (B)
western blot and (C) RT-PCR analyses. Treatment
conditions are indicated in the top of each lane.
‘‘Untreated’’ indicates that P19 cells are not treated
with Skp or any neurogenesis inducer.Skp-Transduced P19 Cells Are Differentiated into
Functionally Active Neurons by Treatment with Nz or Nzl
One challenge in exploiting useful neurogenesis-inducing agents
is the requirement that the substances promote differentiation of
cells into functionally active neurons. Therefore, an important
goal is the differentiation of Skp-transduced pluripotent cells
into neurons with electrophysiological attributes. It has been
shown that voltage-gated sodium (Nav) channels are essential
for action potential generation and electrical excitability in neu-
rons (Yu and Catterall, 2003). To investigate the electrophysio-
logical properties of P19 cells derived by sequential treatment
with Skp and Nz or Nzl, the transcriptional levels of Nav channels
were initially examined by using RT-PCR analysis. The results
show that expression levels of several sodium channel tran-
scripts, including SCN1A, SCN2A1, SCN3A, and SCN8A, in
differentiated P19 cells are upregulated by treatment with Skp
and Nz or Nzl (Figure S4).
Encouraged by these results, we next examined the electro-
physiological activities of neuron-like cells generated by sequen-
tial treatment with Skp and Nz or Nzl. For this purpose, Skp-
transduced P19 cells were incubated with either Nz or Nzl for
3 weeks and whole-cell patch-clamp analyses were then con-
ducted on the differentiated P19 cells. We observed that
neuron-like cells generated by sequential treatment with Skp
and Nz or Nzl exhibited active membrane properties with an
average resting membrane potential of 60 mV in response to
the depolarizing current pulses. Whole-cell currents induced by
10 mV depolarizing voltage steps from 60 mV to +20 mV
were measured in the voltage-clamp mode. Fast-inactivating in-
ward and outward currents were observed in ca. 70% of re-
corded cells (Figures 4A and 4B). However, in the presence of
tetrodotoxin (TTX), which is a selective blocker of sodium chan-
nels (Xie et al., 1994), step depolarization-induced currents in
treated cells were not detected, indicating that the recorded cur-
rent in the differentiated P19 cells is sodium channel dependent.
The neuron-like cells derived by treatment of P19 cells with
Skp and Nz or Nzl were also subjected to a current pulse to
examine the capability of generating depolarization-induced ac-Chemistry & Biology 22, 1512–1520, November 19, 2015tion potentials. The results from current-
clamp measurements showed that a rela-
tively high amplitude of action potentials
was elicited in differentiated P19 cells bycurrent injection, a phenomenon that was completely abolished
in the presence of TTX (Figures 4C and 4D). Together, the obser-
vations support the conclusion that P19 cells are differentiated
into electrophysiologically active neurons by sequential treat-
ment with Skp along with either Nz or Nzl.
Signaling Pathway Study
To elucidate the underlying mechanism of neurogenesis in
pluripotent P19 cells induced by sequential treatment with Skp
and Nz or Nzl, the effects of these substances on neurogene-
sis-related signaling pathways were explored. In this effort, we
initially examined whether these substances affect the Wnt/
b-catenin signaling pathway, which is considered to be a key
regulator of neuronal differentiation (Chenn and Walsh, 2003;
Clevers, 2006; Gulacsi and Anderson, 2008). Skp-transduced
P19 cells were incubated for 9 days with Nz or Nzl in the pres-
ence or absence of Wnt pathway inhibitors, NSC668036
(25 mm) and PKF118-310 (25 nm). It is known that NSC668036
binds to the PDZ domain of the Disheveled (Dsh) protein, a
Wnt pathway signaling molecule (Zhang et al., 2009), and
PKF118-310 blocks the complex formation of Tcf4 and b-catenin
in the Wnt pathway (Lepourcelet et al., 2004). The results of
immunocytochemistry, western blot, and RT-PCR analyses indi-
cate that neurogenesis of sequentially treated P19 cells is greatly
reduced in the presence of each of these inhibitors compared
with that of cells untreated with an inhibitor (Figures 5A–5C
and Figures S5A–S5C). It was anticipated that expression of
b-catenin, which is a key mediator of the Wnt pathway, would
be decreased in inhibitor-treated P19 cells. Indeed, the results
of western blot analysis showed that the translational level of
b-catenin in inhibitor-treated cells was markedly attenuated
compared with that in cells untreated with an inhibitor. We also
examined the expression level ofNeuroD, a representative target
gene in the Wnt pathway, using RT-PCR analysis (Vanderhae-
ghen, 2009). The results show that the transcriptional level of
NeuroD is abrogated in the inhibitor-treated cells.
It is known that the Notch signaling pathway is another key
regulatory pathway in neuronal differentiation (Suh et al., 2009),ª2015 Elsevier Ltd All rights reserved 1515
Figure 4. Electrophysiological Properties of P19 Cells Differentiated
by Sequential Treatment with Skp and Neurogenesis Inducers
P19 cells transduced with Skp (20 mg/ml) during EB formation were incubated
with 3 mm Nz or 4 mm Nzl for 3 weeks. Representative traces of whole-cell
currents recorded from differentiated P19 cells by sequential treatment with
Skp and either (A) Nz or (B) Nzl. The current induced by depolarizing voltage
ranged from 60 mV to +20 mV, with a 10-mV step before (top) and after
(bottom) 0.5 mm TTX perfusion (n = 5/7 of recorded cells). The scales of time
and current are presented. Insets show respective traces on an expanded
scale. Representative traces of an action potential recorded from differenti-
ated P19 cells by sequential treatment with Skp and either (C) Nz or (D) Nzl. The
voltage was recorded in current-clamp mode in response to depolarization by
current injection before (top) and after (bottom) 0.5 mmTTXperfusion (n = 5/7 of
recorded cells). The scales of time and voltage are presented.and that Sox2 activity plays an important role in regulation of the
Notch pathway (Taranova et al., 2006). To test if the Notch
pathway is involved in neurogenesis of P19 cells induced by
sequential treatment with Skp and Nz or Nzl, Skp-transduced
P19 cells were incubated for 9 days with Nz or Nzl in the pres-
ence or absence of MK0752, which is an inhibitor of g-secretase
in the Notch signaling pathway (Gounder and Schwartz, 2012).
The results of immunocytochemical, western blot, and RT-PCR
analyses show that the inhibitor remarkably suppresses neuro-
genesis of the sequentially treated P19 cells (Figures 5D–5F
and Figures S5D–S5F). In addition, we examined the expression
of the Notch pathway target gene, Hes5, using RT-PCR analysis
(Ohtsuka et al., 1999). The results show that the mRNA level of1516 Chemistry & Biology 22, 1512–1520, November 19, 2015 ª2015the gene is greatly reduced in inhibitor-treated cells. In contrast,
Cur61414 (25 mm), an inhibitor of smoothened (SMO) in the Shh
signaling pathway (Williams et al., 2003), has little inhibitory ef-
fect on neuronal differentiation of P19 cells induced by treatment
with Skp and Nz or Nzl (Figure S6). Moreover, analysis of DNA
chip data also shows that genes related to Notch and Wnt
signaling pathways are upregulated, but most genes related to
the Shh pathway are not changed significantly during differenti-
ation of P19 cells induced by sequential treatment with Skp and
Nz (Table S4). Taken together, the results of signaling pathway
studies support the conclusion that combined treatment with
Skp with Nz or Nzl promotes neurogenesis in P19 cells by acti-
vating Wnt and Notch signaling pathways.
DISCUSSION
PSCs are unique in that they grow in suspension to form spher-
ical-shaped cell aggregates known as EB, which can be further
differentiated into most cell types through three germ layers
(Desbaillets et al., 2000). Recently, it was reported that functional
inhibition of Sox2, one of the critical factors for maintaining the
self-renewing ability of embryonic stem cells through positive
and/or negative regulation of a plethora of downstream genes
(Loh et al., 2006), is the key to suppress stemness and enhance
the efficacy of generic differentiation during EB formation (De
et al., 2014). In an attempt to target this enhanced generic
differentiation approach at a tissue-specific lineage, and to
demonstrate that this phenomenon could result in efficient
generation of functional cell types, we designed a neuronal dif-
ferentiation protocol that combined the Skp-induced stemness
inhibition with neurogenesis inducers. The results of RT-PCR
analysis, indicating that upregulation of lineage-specific genes
and silencing of stemness-associated genes occurs in Skp-
transduced cells, support the feasibility of this novel strategy.
We proposed that neuronal differentiation of P19 would be
maximized when P19 cells are subjected to optimal differentia-
tion conditions with the stemness inhibitor and a lineage-specific
inducer. To test this idea, differentiation of P19 cells was carried
out by pretreatment with Skp followed by incubation with small
molecule neurogenesis inducers. We observed that neuronal
commitment of Skp-transduced P19 cells was substantially
improved by treatment with Nz or Nzl (more than 50%of the neu-
rogenesis efficiency), although only less than 10% of the neuro-
genesis efficiency was observed in cells treated with Skp alone
(Figure 6). It was also found that when P19 cells, which were
neither pretreated nor chemically induced with Skp during EB
formation, were incubated with Nz or Nzl during the differentia-
tion phase, they were only minimally converted to neurogenic
cells (Figure 6). This finding indicates that a specific chemical
inducer or Skp should be added to P19 cell cultures during EB
formation to induce efficient differentiation. Importantly, sequen-
tial treatment of P19 cells with Skp followed by Nz or Nzl led to
selective neuronal differentiation because cardiogenesis and as-
trogenesis were suppressed. However, RA treatment of Skp-
transduced P19 cells promoted astrogenesis, indicating that
Nz and Nzl are more selective neurogenic inducers than RA.
These results suggest that improved neuronal commitment
of P19 cells is attributable to cooperative activities of Skp and
either Nz or Nzl. As a result, treatment of Skp-transducedElsevier Ltd All rights reserved
Figure 5. Effect of an Inhibitor of the Wnt or Notch Pathway on Neurogenesis of P19 Cells Induced by Sequential Treatment with Skp and Nz
(A) Skp-transduced P19 cells were incubated for 9 days with 3 mm Nz in the absence (left) and presence of 25 mm NSC668036 (middle) or 25 nM PFK118-310
(right). The cells were immunostained with Tuj1 antibody (scale bar represents 50 mm).
(B) The effect of NSC668036 or PFK118-310 on the expression of b-catenin and Tuj1 in the treated P19 cells was examined by western blot analysis.
(C) The effect of NSC668036 or PFK118-310 on the expression of Tuj1 and NeuroD in the treated P19 cells was examined using RT-PCR analysis.
(D) Skp-transduced P19 cells were incubated for 9 days with 3 mmNz in the absence (left) or presence (right) of 25 mmMK0752. The cells were stained with Tuj1
antibody (scale bar represents 50 mm).
(E) The effect of MK0752 on the expression of Tuj1 in treated P19 cells was examined using western blot analysis.
(F) The effect of MK0752 on the expression of Tuj1 and Hes5 in treated P19 cells was examined using RT-PCR analysis.P19 cells with neurogenesis inducers selectively converts plurip-
otent cells into neurogenic cells with a high efficiency compared
with cells treated with Skp or inducers alone. More importantly,
Skp-transduced P19 cells are differentiated into functional
neurons by treatment with Nz or Nzl, as demonstrated by the
observations that the differentiated cells generated voltage-
dependent inward and outward sodium currents and depolariza-
tion-induced action potentials.
In addition, to shed light on the underlying mechanism of
neuronal differentiation in P19 cells promoted by sequential
treatment of Skp and Nz or Nzl, the effects of these substances
on the signaling pathways associated with neurogenesis were
evaluated. It is well known that neurogenesis is tightly regulated
by multiple signaling pathways, including the canonical Wnt/
b-catenin, Shh, and Notch pathways (Suh et al., 2009). These
three pathways play important roles in the development of
neuronal circuits and are also involved in modulating synaptic
transmission and plasticity in the adult brain. The observations
made in the signaling pathway studies reveal that the efficiency
of neurogenesis of P19 cells promoted by sequential treatment
with Skp and Nz or Nzl is markedly attenuated in the presence
of an inhibitor for the Wnt or Notch pathway, but is only slightly
reduced by an inhibitor for the Shh pathway. These results
were also supported by the results of transcriptome analysis,
which show that genes related to Wnt and Notch pathways are
upregulated and that no significant changes occur in genes
associated with the Shh pathway. Thus,Wnt andNotch signaling
pathways are mainly involved in Nz- or Nzl-promoted neuronal
differentiation of Skp-transduced P19 cells. It is worthwhile
mentioning that treatment with Nz or Nzl during EB and differen-Chemistry & Biology 22, 1512–152tiation phases promoted neurogenesis of P19 cells by activating
Wnt and Shh pathways (Kim et al., 2014). The different signaling
associated with neurogenesis induced by these two methods
might be reflected by the effect of Skp.
In conclusion, in this investigation we developed a strategy
that utilizes a combination of stemness inhibition and lineage-
specific induction to convert pluripotent P19 cells selectively
and efficiently into functionally active neurons. Consequently,
this study not only has led to an efficient stepwise protocol for
neuronal differentiation, but it has also opened new avenues
for developing a general cell differentiation strategy. Finally, the
approach developed in this study has enormous prospects for
being used to understand the molecular mechanisms underlying
cellular plasticity and neurogenesis, which will be important ulti-
mately for designing more effective cell-based therapies.
SIGNIFICANCE
Differentiation of pluripotent cells into a specific cell type is
of great importance for the development of regenerative
medicine and for understanding the mechanisms regulating
differentiation of stem cells. Nonetheless, successful impli-
cations of cell-based therapies are often marred by low effi-
ciencies of commitment. In the present study, we have
developed a protocol to convert pluripotent P19 cells into
electrophysiologically active neurons in an efficient manner.
The approach relies on forced suppression of stemness
followed by lineage-specific induction of neurogenesis,
which results in significant enhancement of commitment
efficiency. Therefore, the new method not only serves as0, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1517
Figure 6. Schematic Model Depicting Neuronal Differentiation of
P19 Cells Induced by Skp and/or Neurogenesis Inducers
Each curve is approximated based on the expression level of neuronal markers
in P19 cells sequentially treated with or without Skp and/or chemical inducers
(Nz/Nzl). The a.u. representing the relative amount of neuronal markers are on
the Y axis.a valuable tool for efficiently producing functionally active
neurons but it also demonstrates a new strategy for
designing efficient lineage commitment for cell therapy.
EXPERIMENTAL PROCEDURES
Cell Culture
Mouse embryonic carcinoma P19 cells (ATCC) were maintained at a relatively
high density in culture medium (RPMI 1640 medium supplemented with 10%
fetal bovine serum (FBS) and 50 units/ml penicillin and 50 mg/ml streptomycin)
according to a previously established protocol (Kim et al., 2014; Fathi et al.,
2009). The cells were grown to confluence in a humidified atmosphere (5%
CO2) at 37
C in 100-cm2 tissue culture dishes. The cells were sub-cultured af-
ter they formed a confluent monolayer (approximately 48 hr).
Neurogenesis of P19 Cells
P19 cells were seeded at a density of 106 cells/ml in 90-mm petri dishes under
nonadherent culture conditions and allowed to aggregate for 3 days in the
presence or absence of Skp (20 mg/ml) conjugated by a cell-penetrating TAT
peptide and an NLS at the N terminus (TAT-NLS-Skp) (De et al., 2014). Aggre-
gated embryonic bodies were dissociated into single cells by treatment with
0.25% trypsin-EDTA solution. Cells were seeded in a tissue culture dish at a
density of approximately 104 cells/ml in culture medium. After incubation for
24 hr, the culture medium was replaced with differentiation medium (RPMI
1640 supplemented with 5% FBS, 50 units/ml penicillin, 50 mg/ml strepto-
mycin) containing 3 mm Nz, 4 mm Nzl, or 0.1 mm RA. Differentiation medium
was replenished every 2 days. Cells were harvested and analyzed during
differentiation.
Immunocytochemistry
The treated P19 cells were fixed for 20 min with 4% paraformaldehyde and
0.1% Triton X-100 in PBS and then washed with PBS. The fixed cells were
incubated in a blocking solution (PBS containing 0.5% FBS) for 1 hr at room
temperature to reduce nonspecific adsorption of antibodies. The cells were
treated with diluted primary antibodies in a blocking solution for 1 hr at room
temperature or overnight at 4C and then washed with PBS. The cells were
then treated with biotin-labeled secondary antibodies, followed by incuba-
tion with Cy3-conjugated streptavidin in a blocking solution for 1 hr at
room temperature. Primary antibodies were used in the following dilutions:
mouse monoclonal to Tuj1 (Santa Cruz), 1:200; mouse monoclonal to NSE1518 Chemistry & Biology 22, 1512–1520, November 19, 2015 ª2015(Santa Cruz), 1:200; rabbit polyclonal to NF200 (Sigma-Aldrich), 1:200;
rabbit polyclonal to MAP2 (Santa Cruz), 1:200; rabbit polyclonal to Nkx2.5
(Abcam), 1:100; mouse monoclonal to MHC-II (Abcam), 1:200; rabbit
polyclonal to GFAP (Abcam), 1:200; rabbit polyclonal to S100 (Abcam),
1:100. Biotin-conjugated goat anti-mouse IgG, goat anti-rabbit IgG, Alexa
Fluor 488-conjugated goat anti-mouse IgG and goat anti-rabbit IgG were
used as secondary antibodies. After staining, cells were washed several
times and microscopic analysis was performed by using a Nikon Eclipse
TE2000 microscope.
Western Blot Analysis
Proteins were separated by using 8% or 10% SDS-PAGE and transferred to
membranes (Amersham Biotech). The membranes were incubated in a block-
ing solution (Tris-buffered saline [TBS] containing 5% nonfat skim milk and
0.5% Tween 20) for 1–2 hr at room temperature to reduce nonspecific adsorp-
tion of antibodies. After washing with TBST (TBS containing 0.5% Tween 20),
the membranes were incubated with diluted primary antibodies in TBST for
1 hr at room temperature or overnight at 4C. After the membranes were
washed with TBST, they were treated with diluted secondary antibodies in
TBST for 1 hr at room temperature. The treated membranes were visualized
using the ECL kit (Amersham Biotech). Primary antibodies were used in
the following dilutions: mouse monoclonal to Tuj1 (Santa Cruz), 1:1,000;
mouse monoclonal to NSE (Santa Cruz), 1:1,000; rabbit polyclonal to
NF200 (Sigma-Aldrich), 1:1,000; mouse monoclonal to GAP43 (Santa Cruz),
1:1,000; mouse monoclonal to NeuN (Millipore), 1:1,000; rabbit polyclonal to
Nkx2.5 (Abcam), 1:1,000; mousemonoclonal toMHC-II (Abcam), 1:1,000; rab-
bit polyclonal to GFAP (Abcam), 1:1,000; rabbit polyclonal to S100 (Abcam),
1:1,000; rabbit polyclonal to b-catenin (Santa Cruz), 1:1,000. Peroxidase-con-
jugated goat anti-mouse IgG, goat anti-rabbit IgG, and goat anti-mouse IgM
were used as secondary antibodies.
Reverse Transcription Polymerase Chain Reaction
Total RNAs were isolated using easy-BLUE (iNtRON Biotechnology) from the
treated P19 cells after indicated times and were subjected to cDNA synthesis
using oligo(dT) primers and a Superscript II reverse transcriptase (Invitrogen),
according to the manufacturer’s instructions. The resulting cDNAs were used
to analyze genes of interest using RT-PCR with the Bio-Rad PCR system. The
PCRprimer sequences targeting for the experimental genes shown in Table S5
were purchased from Bioneer.
Electrophysiology
After differentiation of Skp (20 mg/ml)-transduced P19 cells by treatment with
either 3 mmNz or 4 mmNzl for 3 weeks, cells with neuronal morphology (round
cell body and neurite-like processes) were selected for whole-cell patch-
clamp recordings. Cells plated on coverslips were placed in a submerged
recording chamber (Warner Instruments) on a microscope (Olympus). Electro-
physiological recordings were made using a Multiclamp 700B amplifier
(Molecular Devices) and Clampex 10.3 of the pClamp software package
(Molecular Devices). Digitization of voltages and currents were controlled by
Digitizer 1440A (Molecular Devices). Recording electrodes were pulled from
borosilicate capillary glass tubes (Warner Instruments) using a pipet puller
(P-97, Sutter Instrument). Resistance of recording electrodes ranged from
4MU to 6 MUwhen they were filled with intra-pipette solution (115 mM potas-
sium gluconate, 10 mM KCl, 10 mM HEPES, 10 mM EGTA, 5 mM Mg2+-ATP,
and 0.5 mM 2Na+-GTP [pH 7.3], and 280–285 mOsm). Artificial cerebrospinal
fluid was used as external solution (124 mM NaCl, 3 mM KCl, 1.3 mMMgSO4,
1.25 mM NaH2PO4, 26 mM NaHCO3, 10 mM glucose, and 2.4 mM
CaCl2$2H2O). The external solution was aerated by O2 95%/CO2 5% mixed
gas at room temperature. During the whole-cell configuration, the holding po-
tential was clamped to 60 mV in voltage-clamp mode. To measure the so-
dium current, the cell was stimulated in 100-ms voltage steps of depolarization
from the 60 mV holding potential to +20 mV (+10 mV per each step). In cur-
rent-clamp mode, the cells were subjected to a series of current injections to
examine the generation of action potential. Tetrodotoxin (0.5 mm TTX, Sigma
Aldrich) was applied to external solution to confirm the currents and action po-
tentials elicited by Nav channels. After perfusion with TTX in an external solu-
tion for 5–10 min, currents and action potentials were measured by following
the above experimental process.Elsevier Ltd All rights reserved
Signaling Pathway Analysis
P19 cells were seeded at a density of 1 3 106 cells/ml in 90-mm petri dishes
under nonadherent culture conditions and allowed to aggregate for 3 days in
the presence or absence of Skp (20 mg/ml) conjugated by an NLS and a cell-
penetrating TAT peptide at the N terminus. Aggregated embryonic bodies
were dissociated into single cells by treatment with 0.25% trypsin-EDTA solu-
tion. Cells were seeded in a tissue culture dish at a density of approximately
2 3 105 cells/ml in culture medium. After incubation for 24 hr, the culture me-
diumwas replaced with differentiation medium containing 3 mmNz or 4 mmNzl
in the presence or absence of an inhibitor for signaling pathways (an inhibitor
for the Wnt pathway, 25 mm NSC668036 and 25 nm PKF118-310; an inhibitor
for the Notch pathway, 25 mmMK0752; an inhibitor for the Shh pathway, 25 mm
Cur61414). Every 2 days, differentiation medium containing Nz or Nzl without
an inhibitor was replenished. Western blot, immunocytochemical, and RT-
PCR analyses were conducted according to the procedure described earlier.
Statistical Analysis
All data are reported as the mean ± SD from three independent experiments.
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